BioMiStem

BioMiStem is a French biotechnology company specializing in regenerative medicine and autologous adipose-derived stem cell (ADSC) therapies. The company has developed a patented, standardized medical device and protocol for the mechanical isolation of stem cells from fat tissue at the point of care, avoiding the need for enzymatic digestion. Their technology is utilized in plastic surgery, dermatology, and orthopedics to treat conditions such as skin rejuvenation, hair loss, and joint degeneration. BioMiStem maintains strong academic ties with the Paris-Est Créteil University and the Henri Mondor Hospital to advance clinical research in tissue engineering. The company's approach focuses on providing a minimally invasive, same-day procedure for patients using their own biological material.